Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Golatta

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Oncoimmunology|March 5, 2016
Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patientsCarlo Fremd, Stefan Stefanovic, Philipp Beckhove, et al.
Archives of Gynecology and Obstetrics|February 9, 2017
Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center studyAlexandra von Au, Mona Klotzbuecher, Lorenz Uhlmann, et al.
Breast (Edinburgh, Scotland)|May 2, 2021
Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008-2017Fabian Riedel, Ann Sophie Hoffmann, Mareike Moderow, et al.
Insights Into Imaging|August 7, 2024
Shear-wave elastography as a supplementary tool for axillary staging in patients undergoing breast cancer diagnosisRiku Togawa, Fabian Riedel, Manuel Feisst, et al.
JCO Clinical Cancer Informatics|December 23, 2024
Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic TreatmentLie Cai, Thomas M Deutsch, Chris Sidey-Gibbons, et al.
Cancers|January 8, 2025
Evaluation of Ex Vivo Shear Wave Elastography of Axillary Sentinel Lymph Nodes in Patients with Early Breast CancerRiku Togawa, Helena Dahm, Manuel Feisst, et al.
Breast Care (Basel, Switzerland)|May 20, 2024
Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German ExpertsFabian Riedel, Markus Hahn, Werner Bader, et al.
Archives of Gynecology and Obstetrics|December 14, 2017
Oncotype DX<sup>®</sup> in breast cancer patients: clinical experience, outcome and follow-up-a case-control studyMichelle G Rath, Lorenz Uhlmann, Marita Fiedler, et al.
Oncotargets and Therapy|July 29, 2016
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trialAlexandra von Au, Eva Milloth, Ingo Diel, et al.
International Journal of Molecular Sciences|April 5, 2020
The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast CancerStefan Stefanovic, Thomas M Deutsch, Sabine Riethdorf, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Oncoimmunology|March 5, 2016
Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patientsCarlo Fremd, Stefan Stefanovic, Philipp Beckhove, et al.
Archives of Gynecology and Obstetrics|February 9, 2017
Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center studyAlexandra von Au, Mona Klotzbuecher, Lorenz Uhlmann, et al.
Breast (Edinburgh, Scotland)|May 2, 2021
Do hospital type or caseload make a difference in chemotherapy treatment patterns for early breast cancer? Results from 104 German institutions, 2008-2017Fabian Riedel, Ann Sophie Hoffmann, Mareike Moderow, et al.
Insights Into Imaging|August 7, 2024
Shear-wave elastography as a supplementary tool for axillary staging in patients undergoing breast cancer diagnosisRiku Togawa, Fabian Riedel, Manuel Feisst, et al.
JCO Clinical Cancer Informatics|December 23, 2024
Machine Learning to Predict the Individual Risk of Treatment-Relevant Toxicity for Patients With Breast Cancer Undergoing Neoadjuvant Systemic TreatmentLie Cai, Thomas M Deutsch, Chris Sidey-Gibbons, et al.
Cancers|January 8, 2025
Evaluation of Ex Vivo Shear Wave Elastography of Axillary Sentinel Lymph Nodes in Patients with Early Breast CancerRiku Togawa, Helena Dahm, Manuel Feisst, et al.
Breast Care (Basel, Switzerland)|May 20, 2024
Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German ExpertsFabian Riedel, Markus Hahn, Werner Bader, et al.
Archives of Gynecology and Obstetrics|December 14, 2017
Oncotype DX<sup>®</sup> in breast cancer patients: clinical experience, outcome and follow-up-a case-control studyMichelle G Rath, Lorenz Uhlmann, Marita Fiedler, et al.
Oncotargets and Therapy|July 29, 2016
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trialAlexandra von Au, Eva Milloth, Ingo Diel, et al.
International Journal of Molecular Sciences|April 5, 2020
The Lack of Evidence for an Association between Cancer Biomarker Conversion Patterns and CTC-Status in Patients with Metastatic Breast CancerStefan Stefanovic, Thomas M Deutsch, Sabine Riethdorf, et al.
Pageof 14